Abstract:Background: There is currently an unmet clinical need to develop better pharmacological treatments to improve glucose handling in Type II Diabetes patients with obesity. To this end, determining the effect of obesity-associated adipokines on skeletal muscle insulin sensitivity has emerged as an important area of drug discovery research. This review draws together the data on the functional role of adipokines on skeletal muscle insulin signalling, highlights several understudied novel adipokines and provides a perspective on the direction of future research. Main body: The adipokines leptin, resistin, visfatin and adiponectin have all been shown to affect skeletal muscle insulin sensitivity by impacting on the activity of components within insulin signalling pathways, affecting GLUT4 translocation and modulating insulin-mediated skeletal muscle glucose uptake. Furthermore, proteomic analysis of the adipose tissue secretome has recently identified several novel adipokines including vaspin, chemerin and pref-1 that are associated with obesity and insulin resistance in humans and functionally impact on insulin signalling pathways. However, predominantly, these functional findings are the result of studies in rodents, with in vitro studies utilising either rat L6 or murine C2C12 myoblasts and/or myotubes. Despite the methodology to isolate and culture human myoblasts and to differentiate them into myotubes being established, the use of human muscle in vitro models for the functional validation of adipokines on skeletal muscle insulin sensitivity is limited. Conclusion: Understanding the mechanism of action and function of adipokines in mediating insulin sensitivity in skeletal muscle may lead to the development of novel therapeutics for patients with type 2 diabetes. However, to date, studies conducted in human skeletal muscle cells and tissues are limited. Such human in vitro studies should be prioritised in order to reduce the risk of candidate drugs failing in the clinic due to the assumption that rodent skeletal muscle target validation studies will to translate to human.

Adipose Tissue Adipokines and Lipokines: Functions and Regulatory Mechanism in Skeletal Muscle Development and Homeostasis.

New Roles of Lkb1 in Regulating Adipose Tissue Development and Thermogenesis

Bidirectional Roles of Skeletal Muscle Fibro-Adipogenic Progenitors in Homeostasis and Disease.

Myokines mediate the cross talk between skeletal muscle and other organs

Factors Inducing Transdifferentiation Of Myoblasts Into Adipocytes

Editorial: Regulation of Lipid Metabolism in Adipose Tissue and Skeletal Muscle

Myokines: Metabolic Regulation in Obesity and Type 2 Diabetes

The multiple regulatory effects of white adipose tissue on bone homeostasis

Cytokines and exosomal miRNAs in skeletal muscle–adipose crosstalk

Molecular Regulation Mechanism of Animal Adipose Deposition

Brown Adipose Tissue Controls Skeletal Muscle Function via the Secretion of Myostatin

Adipokines in the Crosstalk between Adipose Tissues and Other Organs: Implications in Cardiometabolic Diseases

The Secretory Function of Adipose Tissues in Metabolic Regulation

An update on the secretory functions of brown, white, and beige adipose tissue: Towards therapeutic applications

Adipokines: New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic, and Cardiovascular Diseases

Brown adipose tissue as an endocrine organ: updates on the emerging role of batokines

The role and regulatory mechanism of tissue and organ crosstalk on skeletal muscle development:a review

The role of adipokines in skeletal muscle inflammation and insulin sensitivity

Brown and Beige Fat： the Metabolic Function, Induction, and Therapeutic Potential

A Muscle Hypertrophy-Derived Myokine Reprograms the Stromal Vascular Fractions Differentiation Towards Thermogenic Adipocytes in Subcutaneous Adipose Tissue

Adipose Signals Regulating Distal Organ Health and Disease